The first goal of our proposal is to determine what proportion of various urinary amine metabolities in experimental animals originates in the central nervous system. The metabolites to be studied include the alcoholic metabolites of catacholamines and of trace amines. Concentrations of these metabolites will be determined simultaneously using gas chromatographic-mass spectrometric techniques which we have developed in our laboratory. Two metabolites of particular interest are 3,4-dihydroxyphenylethanol and p-hydroxyphenylglycol, metabolites of dopamine and octopamine, respectively, that we have identified and found to be present in significant quantities in rat brain and urine and in human urine. Our studies should provide a basis for using concentrations of various amine metabolites as useful indicators of the turnover rate of the corresponding amines in the brain of experimental animals as well as in human subjects, and for identifying possible disturbances in amine metabolism that may underlie or result from various psychiatric and neurological illnesses, such as depression and Parkinson's disease. The second goal is to apply these procedures to investigate the extent to which various amino acid precursors are converted to the corresponding amines. For example, we will determine to what extent the synthetic amino acid precursor of octopamine, p-hydroxyphenylserine, is converted to octopamine and its metabolities. These studies could indicate whether this amino acid may be used as a pharmacological tool to selectively increase octopamine formation, in order to elucidate its possible neurochemical role as well as its possible involvement in brain dysfunction. Finally, the effects of both acute and chronic administration of typical and atypical antidepressants on brain amine metabolism will be studied. In particular, we will test the notion that an increased level of octopamine or other trace amines is a common feature of diverse antidepressant agents and may serve as a trigger to the delayed effects of these drugs.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
2R01MH028340-06A1
Application #
3375038
Study Section
(BPNA)
Project Start
1978-07-01
Project End
1988-05-31
Budget Start
1985-06-15
Budget End
1986-05-31
Support Year
6
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
Schools of Dentistry/Oral Hygn
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Edwards, D J; Virji, M A (1990) Hypoaminoacidemia caused by imipramine but not by clenbuterol is dissociable from hyperglycemia and hyperinsulinemia. Life Sci 47:PL13-8
Kuchel, O; Buu, N T; Edwards, D J (1990) Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma. J Lab Clin Med 115:449-53
Edwards, D J; Sorisio, D A; Knopf, S (1989) Effects of the beta 2-adrenoceptor agonist clenbuterol on tyrosine and tryptophan in plasma and brain of the rat. Biochem Pharmacol 38:2957-65
Antelman, S M; Knopf, S; Kocan, D et al. (1989) Persistent sensitization of clonidine-induced hypokinesia following one exposure to a stressor: possible relevance to panic disorder and its treatment. Psychopharmacology (Berl) 98:97-101
Edwards, D J; Sorisio, D A (1988) Effects of imipramine on tyrosine and tryptophan are mediated by beta-adrenoceptor stimulation. Life Sci 42:853-62
Edwards, D J; Sorisio, D A (1988) Differential effects of yohimbine and phenoxybenzamine on norepinephrine metabolites in rat brain. Res Commun Chem Pathol Pharmacol 62:195-206
Edwards, D J; Sorisio, D A; Sedlock, M L (1988) Decreases in tyrosine and p-hydroxyphenylglycol caused by various antidepressants. Biochem Pharmacol 37:2069-75
Edwards, D J; Sorisio, D A; Sedlock, M L (1988) On the mechanism of imipramine's influence in lowering p-hydroxyphenylglycol concentrations in the brain. The role of tyrosine. Biochem Pharmacol 37:2059-67
Edwards, D J; Sorisio, D; Knopf, S et al. (1986) Assay for L-p-tyrosine in plasma and brain by column liquid chromatography with electrochemical detection using m-tyrosine as the internal standard. J Chromatogr 383:142-7
Edwards, D J; Ravitch, J; Knopf, S (1985) Effects of debrisoquin on the excretion of catecholamine and octopamine metabolites in the rat and guinea pig. Biochem Pharmacol 34:2911-6

Showing the most recent 10 out of 14 publications